<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045911</url>
  </required_header>
  <id_info>
    <org_study_id>Endo-barbed clips suturing</org_study_id>
    <nct_id>NCT05045911</nct_id>
  </id_info>
  <brief_title>An Endoscopic Barbed-clips Suturing for Colorectal ESD</brief_title>
  <official_title>A Novel Endoscopic Barbed-clips Suturing for Mucosal Defect Closure After Endoscopic Submucosal Dissection of Colon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Affiliated Hospital to Academy of Military Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Affiliated Hospital to Academy of Military Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic submucosal dissection (ESD) was developed to allow en bloc resection of colorectal&#xD;
      neoplasm. Although colorectal ESD has been widely accepted as a minimally invasive treatment&#xD;
      option for early colorectal neoplasm, post-ESD bleeding is one of the major adverse events.&#xD;
      After ESD procedure, endoscopists close the defects with devices to prevent complications. A&#xD;
      novel endoscopic barbed-clips suturing has been developed to simplify endoscopic closure. In&#xD;
      this study, the endoscopic barbed-clips will be evaluated when closing defects in the colon&#xD;
      after ESD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopic submucosal dissection (ESD) has emerged as a new endoscopic technique that allows&#xD;
      en-bloc resection of GI lesions, irrespective of size. The most common complications of the&#xD;
      ESD techniques are bleeding and perforation. Several reports have shown that if prophylactic&#xD;
      closure of a mucosal defect with clips would reduce the risk of bleeding following endoscopic&#xD;
      intervention by ESD. With the advancements in endoscopic therapy, various techniques for&#xD;
      prevention of post-ESD complications have been reported. However, there have some limitations&#xD;
      including their inability to close large defects and the complexity of the approaches and the&#xD;
      need for expensive equipment to complete the procedure. To address these issues, we have&#xD;
      devised a novel endoscopic barbed-clips suturing method for mucosal defect closure after&#xD;
      endoscopic submucosal dissection of colon. In this study, we assessed the technical&#xD;
      feasibility of this novel technique.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 20, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The technical success rate</measure>
    <time_frame>1 day</time_frame>
    <description>Rate of completely closure of the ESD defect</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endoscopic barbed-clips suturing closure time</measure>
    <time_frame>1 day</time_frame>
    <description>The time required to close the defect using endoscopic barbed-clips suturing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients reported with bleeding/perforation post-ESD procedure</measure>
    <time_frame>7 days</time_frame>
    <description>Conduct follow-ups for risk of bleeding and perforation after closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clips used post-ESD</measure>
    <time_frame>7 days</time_frame>
    <description>Record number of clips needed to close lesion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Endoscopic Barbed-clips Suturing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be closed the mucosal defect after colorectal ESD using Endoscopic Barbed-clips Suturing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic Barbed-clips Suturing</intervention_name>
    <description>Endoscopic Barbed-clips Suturing</description>
    <arm_group_label>Endoscopic Barbed-clips Suturing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged≥20 years with a single clinically or histologically diagnosed colorectal lesions&#xD;
             of 20-50mm eligible for which fulfilled criteria for ESD;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with coagulopathy (platelet count &lt; 5 × 10*4, prothrombin time international&#xD;
             normalized ratio &gt; 2,&#xD;
&#xD;
          -  medical conditions requiring the continuous use of antithrombotic agents&#xD;
&#xD;
          -  prior abdominal surgery or radiation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yiliang Bi, Dr.</last_name>
    <phone>+8613240439961</phone>
    <email>yiliangbi@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pei Deng, Dr.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Fifth Medical Center of Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100071</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Min, Dr.</last_name>
      <phone>+8613426165452</phone>
      <email>minmin823@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yan Liu, Pro.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Medical Center of Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Liu</last_name>
      <phone>+8613911798288</phone>
      <email>13911798288@163.com</email>
    </contact>
    <investigator>
      <last_name>Yan Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

